Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- AMO Pharma Limited
- Target Recruit Count
- 76
- Registration Number
- NCT05004129
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Stanford University, Palo Alto, California, United States
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- AMO Pharma Limited
- Target Recruit Count
- 56
- Registration Number
- NCT03692312
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Stanford University, Palo Alto, California, United States
Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy
- First Posted Date
- 2016-08-08
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- AMO Pharma Limited
- Target Recruit Count
- 16
- Registration Number
- NCT02858908
- Locations
- 🇬🇧
Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle Upon Tyne, Tyne And Wear, United Kingdom
News
No news found